GoodRx Holdings (GDRX) Total Non-Current Liabilities (2019 - 2026)

GoodRx Holdings has disclosed Total Non-Current Liabilities across 8 years of filings, most recently posting $1.7 billion for Q2 2026.

• In Q2 2026, Total Non-Current Liabilities rose 152.23% year-over-year to $1.7 billion; the TTM figure through Jun 2026 stood at $1.7 billion (up 152.23% YoY), while the FY2025 annual figure was $779.1 million, up 18.64% from the prior year.
• Total Non-Current Liabilities came in at $1.7 billion for Q2 2026 at GoodRx Holdings, up from $1.4 billion in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $1.7 billion in Q2 2026 to a low of $634.0 million in Q1 2025.
• Average Total Non-Current Liabilities over 5 years is $836.8 million, with a median of $777.5 million recorded in 2023.
• Year-over-year, Total Non-Current Liabilities retreated 22.16% in 2025 and jumped 152.23% in 2026.
• Over 5 years, Total Non-Current Liabilities stood at $782.2 million in 2022, then grew by 4.66% to $818.7 million in 2023, then retreated by 19.79% to $656.7 million in 2024, then gained by 18.64% to $779.1 million in 2025, then surged by 116.48% to $1.7 billion in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $1.7 billion in Q2 2026, $1.4 billion in Q1 2026, and $779.1 million in Q4 2025.